FABP3 and non-small cell lung carcinoma: Kaplan-Meier survival curves further confirmed that NSCLC patients with high FABP3 protein expression, high FABP4 protein expression, or advanced TNM stage had significantly shorter overall survival time in NSCLC (Figure 3).